Manhattan Behavior Medicine — New York, New York

Manhattan Behavior Medicine is a clinical research site located in New York, New York, United States 10036.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Manhattan Behavior Medicine has participated in 1 clinical trials.

Therapeutic areas: Binge Eating Disorder.

Sponsors: Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Manhattan Behavior Medicine?

Manhattan Behavior Medicine has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Manhattan Behavior Medicine conducted?

Manhattan Behavior Medicine has 1 clinical trials on record. Their work covers Binge Eating Disorder.

Is Manhattan Behavior Medicine accredited by Crixeo Health?

Manhattan Behavior Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Manhattan Behavior Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.